Cigna Group (CI) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/02/cigna-group-ci-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 02, 2024 - CI earnings call for the period ending December 31, 2023.
0
Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up
https://www.zacks.com/stock/news/2220493/cigna-ci-q4-earnings-beat-on-membership-growth-dividend-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2220493
Feb 02, 2024 - Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.
0
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage
https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560
Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
0
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers
https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169
Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
0
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
https://www.zacks.com/stock/news/2238726/the-joint-jynt-rises-30-as-q4-earnings-beat-on-higher-clinics?cid=CS-ZC-FT-analyst_blog|earnings_article-2238726
Mar 11, 2024 - The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.
0
Why Elevance (ELV) is a Smart Addition to Your Portfolio Now
https://www.zacks.com/stock/news/2241626/why-elevance-elv-is-a-smart-addition-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2241626
Mar 15, 2024 - Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.
0
Here's Why You Should Retain Centene (CNC) Stock for Now
https://www.zacks.com/stock/news/2242211/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242211
Mar 18, 2024 - Robust growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
0
Why Cigna (CI) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2246671/why-cigna-ci-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2246671
Mar 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Top Research Reports for Walmart, Linde & IBM
https://www.zacks.com/commentary/2247419/top-research-reports-for-walmart-linde-ibm?cid=CS-ZC-FT-research_daily-2247419
Mar 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Linde plc (LIN) and International Business Machines Corporation (IBM).
0
Humana's (HUM) Medicaid Business Teams Up With CPESN USA in Ohio
https://www.zacks.com/stock/news/2249894/humana-s-hum-medicaid-business-teams-up-with-cpesn-usa-in-ohio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249894
Apr 03, 2024 - Humana's (HUM) partnership with CPESN USA in Ohio aims to overcome barriers like limited access to healthcare services in rural and underserved communities.
0
Page 1>